speb/financial-data huggingface dataset:
CXI.TO income_statement (annual, 2022-10-31) — Tax Provision: 2429433.00
CXI.TO income_statement (annual, 2022-10-31) — Tax Rate For Calcs: 0.17
CXI.TO balance_sheet (annual, 2022-10-31) — Taxes Receivable: 0.00
CXI.TO balance_sheet (annual, 2022-10-31) — Total Assets: 125528832.00
CXI.TO balance_sheet (annual, 2022-10-31) — Total Capitalization: 69305509.00
CXI.TO balance_sheet (annual, 2022-10-31) — Total Debt: 10460906.00
CXI.TO balance_sheet (annual, 2022-10-31) — Total Equity Gross Minority Interest: 69305509.00
CXI.TO income_statement (annual, 2022-10-31) — Total Expenses: 48406271.00
CXI.TO balance_sheet (annual, 2022-10-31) — Total Liabilities Net Minority Interest: 56223323.00
CXI.TO balance_sheet (annual, 2022-10-31) — Total Non Current Assets: 13090173.00
CXI.TO balance_sheet (annual, 2022-10-31) — Total Non Current Liabilities Net Minority Interest: 4163543.00
CXI.TO income_statement (annual, 2022-10-31) — Total Operating Income As Reported: 18721473.00
CXI.TO income_statement (annual, 2022-10-31) — Total Other Finance Cost: 2171586.00
CXI.TO balance_sheet (annual, 2022-10-31) — Total Tax Payable: 2166087.00
CXI.TO income_statement (annual, 2022-10-31) — Total Unusual Items: -1472299.00
CXI.TO income_statement (annual, 2022-10-31) — Total Unusual Items Excluding Goodwill: -1472299.00
CXI.TO balance_sheet (annual, 2022-10-31) — Working Capital: 60378879.00
CXI.TO income_statement (annual, 2023-10-31) — +Operating Expense: 30951889.00
CXI.TO income_statement (annual, 2023-10-31) — +Total Revenue: 81954769.00
CXI.TO balance_sheet (annual, 2023-10-31) — Accounts Payable: 21021910.00
CXI.TO balance_sheet (annual, 2023-10-31) — Accounts Receivable: 21125546.00
CXI.TO balance_sheet (annual, 2023-10-31) — Accumulated Depreciation: -3759833.00
CXI.TO balance_sheet (annual, 2023-10-31) — Additional Paid In Capital: 32827629.00
CXI.TO balance_sheet (annual, 2023-10-31) — Allowance For Doubtful Accounts Receivable: -400000.00
CXI.TO cash_flow (annual, 2023-10-31) — Asset Impairment Charge: 0.00
CXI.TO income_statement (annual, 2023-10-31) — Basic Average Shares: 6424751.00
CXI.TO income_statement (annual, 2023-10-31) — Basic EPS: 1.59
CXI.TO cash_flow (annual, 2023-10-31) — Beginning Cash Position: 88559268.00
CXI.TO balance_sheet (annual, 2023-10-31) — Buildings And Improvements: 2558433.00
CXI.TO cash_flow (annual, 2023-10-31) — Capital Expenditure: -1290023.00
CXI.TO balance_sheet (annual, 2023-10-31) — Capital Lease Obligations: 2966719.00
CXI.TO balance_sheet (annual, 2023-10-31) — Capital Stock: 6443397.00
CXI.TO balance_sheet (annual, 2023-10-31) — Cash And Cash Equivalents: 92720293.00
CXI.TO balance_sheet (annual, 2023-10-31) — Cash Cash Equivalents And Short Term Investments: 92720293.00
CXI.TO balance_sheet (annual, 2023-10-31) — Cash Financial: 92720293.00
CXI.TO cash_flow (annual, 2023-10-31) — Cash Flow From Continuing Financing Activities: 6916000.00
CXI.TO cash_flow (annual, 2023-10-31) — Cash Flow From Continuing Investing Activities: -1280023.00
CXI.TO cash_flow (annual, 2023-10-31) — Cash Flow From Continuing Operating Activities: -1131607.00
CXI.TO cash_flow (annual, 2023-10-31) — Change In Account Payable: -10716789.00
CXI.TO cash_flow (annual, 2023-10-31) — Change In Other Current Assets: 2874458.00
CXI.TO cash_flow (annual, 2023-10-31) — Change In Other Working Capital: -193028.00
CXI.TO cash_flow (annual, 2023-10-31) — Change In Payable: -10716789.00
CXI.TO cash_flow (annual, 2023-10-31) — Change In Payables And Accrued Expense: -10716789.00
CXI.TO cash_flow (annual, 2023-10-31) — Change In Receivables: -6916259.00
CXI.TO cash_flow (annual, 2023-10-31) — Change In Working Capital: -14951618.00
CXI.TO cash_flow (annual, 2023-10-31) — Changes In Account Receivables: -6916030.00
CXI.TO cash_flow (annual, 2023-10-31) — Changes In Cash: 4504370.00
CXI.TO balance_sheet (annual, 2023-10-31) — Common Stock: 6443397.00
CXI.TO balance_sheet (annual, 2023-10-31) — Common Stock Equity: 79232981.00
CXI.TO cash_flow (annual, 2023-10-31) — Common Stock Payments: 0.00
CXI.TO income_statement (annual, 2023-10-31) — Cost Of Revenue: 33935281.00
CXI.TO balance_sheet (annual, 2023-10-31) — Current Accrued Expenses: 5624280.00
CXI.TO balance_sheet (annual, 2023-10-31) — Current Assets: 120243608.00
CXI.TO balance_sheet (annual, 2023-10-31) — Current Capital Lease Obligation: 1577758.00
CXI.TO balance_sheet (annual, 2023-10-31) — Current Debt: 14679991.00
CXI.TO balance_sheet (annual, 2023-10-31) — Current Debt And Capital Lease Obligation: 16257749.00
CXI.TO balance_sheet (annual, 2023-10-31) — Current Deferred Liabilities: 648818.00
CXI.TO balance_sheet (annual, 2023-10-31) — Current Deferred Revenue: 648818.00
CXI.TO balance_sheet (annual, 2023-10-31) — Current Liabilities: 50097175.00
CXI.TO cash_flow (annual, 2023-10-31) — Depreciation: 3405240.00
CXI.TO cash_flow (annual, 2023-10-31) — Depreciation Amortization Depletion: 3405240.00
CXI.TO income_statement (annual, 2023-10-31) — Depreciation Amortization Depletion Income Statement: 3405240.00
CXI.TO cash_flow (annual, 2023-10-31) — Depreciation And Amortization: 3405240.00
CXI.TO income_statement (annual, 2023-10-31) — Depreciation And Amortization In Income Statement: 3405240.00
CXI.TO income_statement (annual, 2023-10-31) — Depreciation Income Statement: 3405240.00
CXI.TO income_statement (annual, 2023-10-31) — Diluted Average Shares: 6696942.00
CXI.TO income_statement (annual, 2023-10-31) — Diluted EPS: 1.52
CXI.TO income_statement (annual, 2023-10-31) — Diluted NI Availto Com Stockholders: 10193507.00
CXI.TO income_statement (annual, 2023-10-31) — EBIT: 15792850.00
CXI.TO income_statement (annual, 2023-10-31) — EBITDA: 19198090.00
CXI.TO cash_flow (annual, 2023-10-31) — Effect Of Exchange Rate Changes: -343345.00
CXI.TO cash_flow (annual, 2023-10-31) — End Cash Position: 92720293.00
CXI.TO cash_flow (annual, 2023-10-31) — Financing Cash Flow: 6916000.00
CXI.TO cash_flow (annual, 2023-10-31) — Free Cash Flow: -2421630.00
CXI.TO income_statement (annual, 2023-10-31) — Gain On Sale Of Ppe: -30527.00
CXI.TO income_statement (annual, 2023-10-31) — Gain On Sale Of Security: 711763.00
CXI.TO balance_sheet (annual, 2023-10-31) — Gains Losses Not Affecting Retained Earnings: -6584811.00
CXI.TO income_statement (annual, 2023-10-31) — General And Administrative Expense: 20437251.00
CXI.TO balance_sheet (annual, 2023-10-31) — Goodwill: 2172180.00
CXI.TO balance_sheet (annual, 2023-10-31) — Goodwill And Other Intangible Assets: 5840920.00
CXI.TO balance_sheet (annual, 2023-10-31) — Gross Accounts Receivable: 21525546.00
CXI.TO balance_sheet (annual, 2023-10-31) — Gross PPE: 7352496.00
CXI.TO income_statement (annual, 2023-10-31) — Gross Profit: 48019488.00
CXI.TO balance_sheet (annual, 2023-10-31) — Hedging Assets Current: 1066467.00
CXI.TO cash_flow (annual, 2023-10-31) — Income Tax Paid Supplemental Data: 6882949.00
CXI.TO balance_sheet (annual, 2023-10-31) — Income Tax Payable: 635183.00
CXI.TO income_statement (annual, 2023-10-31) — Insurance And Claims: 1179383.00
CXI.TO income_statement (annual, 2023-10-31) — Interest Expense: 1268065.00
CXI.TO income_statement (annual, 2023-10-31) — Interest Expense Non Operating: 1268065.00
CXI.TO income_statement (annual, 2023-10-31) — Interest Income: 435903.00
CXI.TO income_statement (annual, 2023-10-31) — Interest Income Non Operating: 435903.00
CXI.TO cash_flow (annual, 2023-10-31) — Interest Paid Supplemental Data: 920787.00
CXI.TO balance_sheet (annual, 2023-10-31) — Invested Capital: 93912972.00
CXI.TO cash_flow (annual, 2023-10-31) — Investing Cash Flow: -1280023.00
CXI.TO balance_sheet (annual, 2023-10-31) — Leases: 3005454.00
CXI.TO balance_sheet (annual, 2023-10-31) — Line Of Credit: 14679991.00
CXI.TO balance_sheet (annual, 2023-10-31) — Long Term Capital Lease Obligation: 1388961.00
CXI.TO balance_sheet (annual, 2023-10-31) — Long Term Debt And Capital Lease Obligation: 1388961.00
CXI.TO cash_flow (annual, 2023-10-31) — Long Term Debt Payments: -2093022.00
CXI.TO balance_sheet (annual, 2023-10-31) — Machinery Furniture Equipment: 1788327.00
CXI.TO cash_flow (annual, 2023-10-31) — Net Business Purchase And Sale: 0.00
CXI.TO cash_flow (annual, 2023-10-31) — Net Common Stock Issuance: 0.00
CXI.TO income_statement (annual, 2023-10-31) — Net Income: 10193507.00
CXI.TO income_statement (annual, 2023-10-31) — Net Income Common Stockholders: 10193507.00
CXI.TO income_statement (annual, 2023-10-31) — Net Income Continuous Operations: 10193507.00
CXI.TO income_statement (annual, 2023-10-31) — Net Income From Continuing And Discontinued Operation: 10193507.00
CXI.TO income_statement (annual, 2023-10-31) — Net Income From Continuing Operation Net Minority Interest: 10193507.00
CXI.TO cash_flow (annual, 2023-10-31) — Net Income From Continuing Operations: 10193507.00
CXI.TO income_statement (annual, 2023-10-31) — Net Income Including Noncontrolling Interests: 10193507.00
CXI.TO cash_flow (annual, 2023-10-31) — Net Intangibles Purchase And Sale: -528809.00
CXI.TO income_statement (annual, 2023-10-31) — Net Interest Income: -3282515.00
CXI.TO cash_flow (annual, 2023-10-31) — Net Issuance Payments Of Debt: 6759569.00
CXI.TO cash_flow (annual, 2023-10-31) — Net Long Term Debt Issuance: -2093022.00
CXI.TO income_statement (annual, 2023-10-31) — Net Non Operating Interest Income Expense: -3282515.00
CXI.TO cash_flow (annual, 2023-10-31) — Net Other Financing Charges: 179856.00
CXI.TO cash_flow (annual, 2023-10-31) — Net Other Investing Changes: 10000.00
CXI.TO balance_sheet (annual, 2023-10-31) — Net PPE: 3592663.00
CXI.TO cash_flow (annual, 2023-10-31) — Net PPE Purchase And Sale: -761214.00
CXI.TO cash_flow (annual, 2023-10-31) — Net Short Term Debt Issuance: 8852591.00
CXI.TO balance_sheet (annual, 2023-10-31) — Net Tangible Assets: 73392061.00
CXI.TO balance_sheet (annual, 2023-10-31) — Non Current Deferred Assets: 2266114.00
CXI.TO balance_sheet (annual, 2023-10-31) — Non Current Deferred Taxes Assets: 2266114.00
CXI.TO income_statement (annual, 2023-10-31) — Normalized EBITDA: 18516854.00
CXI.TO income_statement (annual, 2023-10-31) — Normalized Income: 9715414.97
CXI.TO cash_flow (annual, 2023-10-31) — Operating Cash Flow: -1131607.00
CXI.TO cash_flow (annual, 2023-10-31) — Operating Gains Losses: -30527.00
CXI.TO income_statement (annual, 2023-10-31) — Operating Income: 17067599.00
CXI.TO income_statement (annual, 2023-10-31) — Operating Revenue: 81954769.00
CXI.TO balance_sheet (annual, 2023-10-31) — Ordinary Shares Number: 6443397.00
CXI.TO balance_sheet (annual, 2023-10-31) — Other Current Assets: 277584.00
CXI.TO balance_sheet (annual, 2023-10-31) — Other Current Liabilities: 5909235.00
CXI.TO balance_sheet (annual, 2023-10-31) — Other Equity Adjustments: -6584811.00
CXI.TO balance_sheet (annual, 2023-10-31) — Other Equity Interest: 3837805.00
CXI.TO income_statement (annual, 2023-10-31) — Other Gand A: 16537451.00
CXI.TO income_statement (annual, 2023-10-31) — Other Income Expense: 739701.00
CXI.TO balance_sheet (annual, 2023-10-31) — Other Intangible Assets: 3668740.00
CXI.TO cash_flow (annual, 2023-10-31) — Other Non Cash Items: -766032.00
CXI.TO balance_sheet (annual, 2023-10-31) — Other Non Current Assets: 106139.00
CXI.TO balance_sheet (annual, 2023-10-31) — Other Non Current Liabilities: 1330327.00
CXI.TO income_statement (annual, 2023-10-31) — Other Non Operating Income Expenses: 58465.00
CXI.TO income_statement (annual, 2023-10-31) — Other Operating Expenses: 7109398.00
CXI.TO balance_sheet (annual, 2023-10-31) — Other Properties: 282.00
CXI.TO balance_sheet (annual, 2023-10-31) — Payables: 21657093.00
CXI.TO balance_sheet (annual, 2023-10-31) — Payables And Accrued Expenses: 27281373.00
CXI.TO balance_sheet (annual, 2023-10-31) — Prepaid Assets: 1573233.00
CXI.TO income_statement (annual, 2023-10-31) — Pretax Income: 14524785.00
CXI.TO cash_flow (annual, 2023-10-31) — Proceeds From Stock Option Exercised: -23425.00
CXI.TO balance_sheet (annual, 2023-10-31) — Properties: 0.00
CXI.TO cash_flow (annual, 2023-10-31) — Purchase Of Business: 0.00
CXI.TO cash_flow (annual, 2023-10-31) — Purchase Of Intangibles: -528809.00
CXI.TO cash_flow (annual, 2023-10-31) — Purchase Of PPE: -761214.00
CXI.TO balance_sheet (annual, 2023-10-31) — Receivables: 21125546.00
CXI.TO income_statement (annual, 2023-10-31) — Reconciled Cost Of Revenue: 33935281.00
CXI.TO income_statement (annual, 2023-10-31) — Reconciled Depreciation: 3405240.00
CXI.TO income_statement (annual, 2023-10-31) — Rent And Landing Fees: 1702594.00
CXI.TO income_statement (annual, 2023-10-31) — Rent Expense Supplemental: 1702594.00
CXI.TO cash_flow (annual, 2023-10-31) — Repayment Of Debt: -2093022.00
CXI.TO cash_flow (annual, 2023-10-31) — Repurchase Of Capital Stock: 0.00
CXI.TO balance_sheet (annual, 2023-10-31) — Restricted Cash: 3480485.00
CXI.TO balance_sheet (annual, 2023-10-31) — Retained Earnings: 42708961.00
CXI.TO income_statement (annual, 2023-10-31) — Salaries And Wages: 1017823.00
CXI.TO income_statement (annual, 2023-10-31) — Selling General And Administration: 20437251.00
CXI.TO balance_sheet (annual, 2023-10-31) — Share Issued: 6443397.00
CXI.TO income_statement (annual, 2023-10-31) — Special Income Charges: -30527.00
CXI.TO cash_flow (annual, 2023-10-31) — Stock Based Compensation: 1017823.00
CXI.TO balance_sheet (annual, 2023-10-31) — Stockholders Equity: 79232981.00
CXI.TO balance_sheet (annual, 2023-10-31) — Tangible Book Value: 73392061.00
CXI.TO income_statement (annual, 2023-10-31) — Tax Effect Of Unusual Items: 203143.97
CXI.TO income_statement (annual, 2023-10-31) — Tax Provision: 4331278.00
CXI.TO income_statement (annual, 2023-10-31) — Tax Rate For Calcs: 0.30
CXI.TO balance_sheet (annual, 2023-10-31) — Total Assets: 132049444.00
CXI.TO balance_sheet (annual, 2023-10-31) — Total Capitalization: 79232981.00
CXI.TO balance_sheet (annual, 2023-10-31) — Total Debt: 17646710.00
CXI.TO balance_sheet (annual, 2023-10-31) — Total Equity Gross Minority Interest: 79232981.00
CXI.TO income_statement (annual, 2023-10-31) — Total Expenses: 64887170.00
CXI.TO balance_sheet (annual, 2023-10-31) — Total Liabilities Net Minority Interest: 52816463.00
CXI.TO balance_sheet (annual, 2023-10-31) — Total Non Current Assets: 11805836.00
CXI.TO balance_sheet (annual, 2023-10-31) — Total Non Current Liabilities Net Minority Interest: 2719288.00
CXI.TO income_statement (annual, 2023-10-31) — Total Operating Income As Reported: 18734249.00
CXI.TO income_statement (annual, 2023-10-31) — Total Other Finance Cost: 2450353.00
CXI.TO balance_sheet (annual, 2023-10-31) — Total Tax Payable: 635183.00
CXI.TO income_statement (annual, 2023-10-31) — Total Unusual Items: 681236.00
CXI.TO income_statement (annual, 2023-10-31) — Total Unusual Items Excluding Goodwill: 681236.00
CXI.TO balance_sheet (annual, 2023-10-31) — Treasury Shares Number: 0.00
CXI.TO balance_sheet (annual, 2023-10-31) — Working Capital: 70146433.00
CXI.TO income_statement (annual, 2023-10-31) — Write Off: 0.00
CXI.TO income_statement (annual, 2024-10-31) — +Operating Expense: 21679788.00
CXI.TO income_statement (annual, 2024-10-31) — +Total Revenue: 68921326.00
CXI.TO balance_sheet (annual, 2024-10-31) — Accounts Payable: 15091074.00
CXI.TO balance_sheet (quarterly, 2024-10-31) — Accounts Payable: 15091074.00
CXI.TO balance_sheet (annual, 2024-10-31) — Accounts Receivable: 8743640.00
CXI.TO balance_sheet (quarterly, 2024-10-31) — Accounts Receivable: 8743640.00
CXI.TO balance_sheet (annual, 2024-10-31) — Accumulated Depreciation: -3304547.00
CXI.TO balance_sheet (annual, 2024-10-31) — Additional Paid In Capital: 30422893.00
CXI.TO balance_sheet (annual, 2024-10-31) — Allowance For Doubtful Accounts Receivable: -171509.00
CXI.TO balance_sheet (quarterly, 2024-10-31) — Allowance For Doubtful Accounts Receivable: -171509.00
CXI.TO cash_flow (annual, 2024-10-31) — Asset Impairment Charge: 2690425.00
CXI.TO balance_sheet (annual, 2024-10-31) — Assets Held For Sale Current: 42021211.00
CXI.TO balance_sheet (quarterly, 2024-10-31) — Assets Held For Sale Current: 42021211.00
CXI.TO income_statement (annual, 2024-10-31) — Basic Average Shares: 6287096.00
CXI.TO income_statement (annual, 2024-10-31) — Basic EPS: 0.39
CXI.TO cash_flow (annual, 2024-10-31) — Beginning Cash Position: 92720293.00
CXI.TO balance_sheet (annual, 2024-10-31) — Buildings And Improvements: 5422660.00
CXI.TO balance_sheet (quarterly, 2024-10-31) — Buildings And Improvements: 5422660.00
CXI.TO cash_flow (annual, 2024-10-31) — Capital Expenditure: -3003123.00
CXI.TO cash_flow (quarterly, 2024-10-31) — Capital Expenditure: -849332.00
CXI.TO balance_sheet (annual, 2024-10-31) — Capital Lease Obligations: 5753310.00
CXI.TO balance_sheet (annual, 2024-10-31) — Capital Stock: 6333931.00
CXI.TO balance_sheet (quarterly, 2024-10-31) — Capital Stock: 6333931.00
CXI.TO balance_sheet (annual, 2024-10-31) — Cash And Cash Equivalents: 66218081.00
CXI.TO balance_sheet (annual, 2024-10-31) — Cash Cash Equivalents And Short Term Investments: 66218081.00
CXI.TO balance_sheet (annual, 2024-10-31) — Cash Financial: 66218081.00
CXI.TO balance_sheet (quarterly, 2024-10-31) — Cash Financial: 66218081.00
CXI.TO cash_flow (annual, 2024-10-31) — Cash Flow From Continuing Financing Activities: -14548280.00
CXI.TO cash_flow (annual, 2024-10-31) — Cash Flow From Continuing Investing Activities: -3003123.00
CXI.TO cash_flow (quarterly, 2024-10-31) — Cash Flow From Continuing Investing Activities: -849332.00
CXI.TO cash_flow (annual, 2024-10-31) — Cash Flow From Continuing Operating Activities: 26902324.00
CXI.TO cash_flow (quarterly, 2024-10-31) — Cash Flow From Continuing Operating Activities: -22567179.00
CXI.TO cash_flow (annual, 2024-10-31) — Change In Account Payable: 4699281.00
CXI.TO cash_flow (annual, 2024-10-31) — Change In Other Current Assets: 468295.00
CXI.TO cash_flow (quarterly, 2024-10-31) — Change In Other Current Assets: -40055.00
CXI.TO cash_flow (annual, 2024-10-31) — Change In Other Working Capital: 1220911.00
CXI.TO cash_flow (annual, 2024-10-31) — Change In Payable: 4699281.00
CXI.TO cash_flow (annual, 2024-10-31) — Change In Payables And Accrued Expense: 4699281.00
CXI.TO cash_flow (quarterly, 2024-10-31) — Change In Payables And Accrued Expense: -27779418.00
CXI.TO cash_flow (annual, 2024-10-31) — Change In Receivables: 10159713.00
CXI.TO cash_flow (quarterly, 2024-10-31) — Change In Receivables: 4122051.00
CXI.TO cash_flow (annual, 2024-10-31) — Change In Working Capital: 16548200.00
CXI.TO cash_flow (annual, 2024-10-31) — Changes In Account Receivables: 10159487.00
CXI.TO cash_flow (quarterly, 2024-10-31) — Changes In Account Receivables: 4122052.00
CXI.TO cash_flow (annual, 2024-10-31) — Changes In Cash: 9350921.00
CXI.TO balance_sheet (annual, 2024-10-31) — Common Stock: 6333931.00
CXI.TO balance_sheet (annual, 2024-10-31) — Common Stock Equity: 79392355.00
CXI.TO balance_sheet (quarterly, 2024-10-31) — Common Stock Equity: 79392355.00
CXI.TO cash_flow (annual, 2024-10-31) — Common Stock Payments: -2749308.00
CXI.TO income_statement (annual, 2024-10-31) — Cost Of Revenue: 27489472.00
CXI.TO income_statement (quarterly, 2024-10-31) — Cost Of Revenue: 9207004.00
CXI.TO balance_sheet (annual, 2024-10-31) — Current Accrued Expenses: 3656947.00
CXI.TO balance_sheet (quarterly, 2024-10-31) — Current Accrued Expenses: 3656947.00
CXI.TO balance_sheet (annual, 2024-10-31) — Current Assets: 118515329.00
CXI.TO balance_sheet (annual, 2024-10-31) — Current Capital Lease Obligation: 1147711.00
CXI.TO balance_sheet (quarterly, 2024-10-31) — Current Capital Lease Obligation: 1147711.00
CXI.TO balance_sheet (annual, 2024-10-31) — Current Debt: 5032894.00
CXI.TO balance_sheet (quarterly, 2024-10-31) — Current Debt: 5032894.00
CXI.TO balance_sheet (annual, 2024-10-31) — Current Debt And Capital Lease Obligation: 1147711.00
CXI.TO balance_sheet (quarterly, 2024-10-31) — Current Debt And Capital Lease Obligation: 1147711.00
CXI.TO balance_sheet (annual, 2024-10-31) — Current Deferred Liabilities: 488773.00
CXI.TO balance_sheet (annual, 2024-10-31) — Current Deferred Revenue: 488773.00
CXI.TO balance_sheet (quarterly, 2024-10-31) — Current Deferred Revenue: 488773.00
CXI.TO balance_sheet (annual, 2024-10-31) — Current Liabilities: 45096043.00
CXI.TO balance_sheet (quarterly, 2024-10-31) — Current Liabilities: 45096043.00
CXI.TO cash_flow (annual, 2024-10-31) — Depreciation: 3770366.00
CXI.TO cash_flow (quarterly, 2024-10-31) — Depreciation: 1057092.00
CXI.TO cash_flow (annual, 2024-10-31) — Depreciation Amortization Depletion: 3770366.00
CXI.TO income_statement (annual, 2024-10-31) — Depreciation Amortization Depletion Income Statement: 3284214.00
CXI.TO income_statement (quarterly, 2024-10-31) — Depreciation Amortization Depletion Income Statement: 1057092.00
CXI.TO cash_flow (annual, 2024-10-31) — Depreciation And Amortization: 3770366.00
CXI.TO income_statement (annual, 2024-10-31) — Depreciation And Amortization In Income Statement: 3284214.00
CXI.TO income_statement (quarterly, 2024-10-31) — Depreciation And Amortization In Income Statement: 1057092.00
CXI.TO income_statement (annual, 2024-10-31) — Depreciation Income Statement: 3284214.00
CXI.TO income_statement (annual, 2024-10-31) — Diluted Average Shares: 6560427.00
CXI.TO income_statement (annual, 2024-10-31) — Diluted EPS: 0.38
CXI.TO income_statement (annual, 2024-10-31) — Diluted NI Availto Com Stockholders: 2473849.00
CXI.TO income_statement (annual, 2024-10-31) — EBIT: 18423136.00
CXI.TO income_statement (quarterly, 2024-10-31) — EBIT: -771572.00
CXI.TO income_statement (annual, 2024-10-31) — EBITDA: 22193502.00
CXI.TO income_statement (quarterly, 2024-10-31) — EBITDA: 285520.00
CXI.TO cash_flow (annual, 2024-10-31) — Effect Of Exchange Rate Changes: -193951.00
CXI.TO cash_flow (annual, 2024-10-31) — End Cash Position: 101877263.00
CXI.TO cash_flow (annual, 2024-10-31) — Financing Cash Flow: -14548280.00
CXI.TO cash_flow (quarterly, 2024-10-31) — Financing Cash Flow: -1430104.00
CXI.TO cash_flow (annual, 2024-10-31) — Free Cash Flow: 23899201.00
CXI.TO cash_flow (quarterly, 2024-10-31) — Free Cash Flow: -23416511.00
CXI.TO income_statement (annual, 2024-10-31) — Gain On Sale Of Ppe: 0.00
CXI.TO income_statement (quarterly, 2024-10-31) — Gain On Sale Of Ppe: 0.00
CXI.TO income_statement (annual, 2024-10-31) — Gain On Sale Of Security: -327301.00
CXI.TO income_statement (quarterly, 2024-10-31) — Gain On Sale Of Security: -379231.00
CXI.TO balance_sheet (annual, 2024-10-31) — Gains Losses Not Affecting Retained Earnings: -6523785.00
CXI.TO balance_sheet (quarterly, 2024-10-31) — Gains Losses Not Affecting Retained Earnings: -6523785.00
CXI.TO income_statement (annual, 2024-10-31) — General And Administrative Expense: 13601571.00
CXI.TO balance_sheet (annual, 2024-10-31) — Goodwill: 1309701.00
CXI.TO balance_sheet (annual, 2024-10-31) — Goodwill And Other Intangible Assets: 3431886.00
CXI.TO balance_sheet (quarterly, 2024-10-31) — Goodwill And Other Intangible Assets: 3431886.00
CXI.TO balance_sheet (annual, 2024-10-31) — Gross Accounts Receivable: 11167827.00
CXI.TO balance_sheet (quarterly, 2024-10-31) — Gross Accounts Receivable: 11167827.00
CXI.TO balance_sheet (annual, 2024-10-31) — Gross PPE: 11093989.00
CXI.TO balance_sheet (quarterly, 2024-10-31) — Gross PPE: 11093989.00
CXI.TO income_statement (annual, 2024-10-31) — Gross Profit: 41431854.00
CXI.TO income_statement (quarterly, 2024-10-31) — Gross Profit: 13842075.00
CXI.TO balance_sheet (annual, 2024-10-31) — Hedging Assets Current: 113511.00
CXI.TO balance_sheet (quarterly, 2024-10-31) — Hedging Assets Current: 113511.00
CXI.TO cash_flow (annual, 2024-10-31) — Income Tax Paid Supplemental Data: 5604320.00
CXI.TO cash_flow (quarterly, 2024-10-31) — Income Tax Paid Supplemental Data: 2525314.00
CXI.TO balance_sheet (annual, 2024-10-31) — Income Tax Payable: 175557.00
CXI.TO balance_sheet (quarterly, 2024-10-31) — Income Tax Payable: 175557.00
CXI.TO income_statement (annual, 2024-10-31) — Insurance And Claims: 800396.00
CXI.TO income_statement (annual, 2024-10-31) — Interest Expense: 465321.00
CXI.TO income_statement (quarterly, 2024-10-31) — Interest Expense: 314932.00
CXI.TO income_statement (annual, 2024-10-31) — Interest Expense Non Operating: 465321.00
CXI.TO income_statement (quarterly, 2024-10-31) — Interest Expense Non Operating: 314932.00
CXI.TO income_statement (annual, 2024-10-31) — Interest Income: 137523.00
CXI.TO income_statement (quarterly, 2024-10-31) — Interest Income: 104819.00
CXI.TO income_statement (annual, 2024-10-31) — Interest Income Non Operating: 137523.00
CXI.TO income_statement (quarterly, 2024-10-31) — Interest Income Non Operating: 104819.00
CXI.TO cash_flow (annual, 2024-10-31) — Interest Paid Supplemental Data: 139240.00
CXI.TO balance_sheet (annual, 2024-10-31) — Invested Capital: 79392355.00
CXI.TO balance_sheet (quarterly, 2024-10-31) — Invested Capital: 79392355.00
CXI.TO cash_flow (annual, 2024-10-31) — Investing Cash Flow: -3003123.00
CXI.TO cash_flow (quarterly, 2024-10-31) — Investing Cash Flow: -849332.00
CXI.TO balance_sheet (annual, 2024-10-31) — Leases: 3120871.00
CXI.TO balance_sheet (annual, 2024-10-31) — Line Of Credit: 5032894.00
CXI.TO balance_sheet (quarterly, 2024-10-31) — Line Of Credit: 5032894.00
CXI.TO balance_sheet (annual, 2024-10-31) — Long Term Capital Lease Obligation: 4605599.00
CXI.TO balance_sheet (quarterly, 2024-10-31) — Long Term Capital Lease Obligation: 4605599.00
CXI.TO balance_sheet (annual, 2024-10-31) — Long Term Debt And Capital Lease Obligation: 4605599.00
CXI.TO balance_sheet (quarterly, 2024-10-31) — Long Term Debt And Capital Lease Obligation: 4605599.00
CXI.TO cash_flow (annual, 2024-10-31) — Long Term Debt Payments: -2119343.00
CXI.TO balance_sheet (annual, 2024-10-31) — Machinery Furniture Equipment: 2550458.00
CXI.TO balance_sheet (quarterly, 2024-10-31) — Machinery Furniture Equipment: 2550458.00
CXI.TO cash_flow (annual, 2024-10-31) — Net Common Stock Issuance: -2749308.00
CXI.TO income_statement (annual, 2024-10-31) — Net Income: 2473849.00
CXI.TO income_statement (quarterly, 2024-10-31) — Net Income: -2817898.00
CXI.TO income_statement (annual, 2024-10-31) — Net Income Common Stockholders: 2473849.00
CXI.TO income_statement (annual, 2024-10-31) — Net Income Continuous Operations: 13188569.00
CXI.TO income_statement (quarterly, 2024-10-31) — Net Income Continuous Operations: -2817898.00
CXI.TO income_statement (annual, 2024-10-31) — Net Income Discontinuous Operations: -10714720.00
CXI.TO income_statement (annual, 2024-10-31) — Net Income From Continuing And Discontinued Operation: 2473849.00
CXI.TO income_statement (quarterly, 2024-10-31) — Net Income From Continuing And Discontinued Operation: -2817898.00
CXI.TO income_statement (annual, 2024-10-31) — Net Income From Continuing Operation Net Minority Interest: 13188569.00
CXI.TO cash_flow (annual, 2024-10-31) — Net Income From Continuing Operations: 2473849.00
CXI.TO cash_flow (quarterly, 2024-10-31) — Net Income From Continuing Operations: -2817898.00
CXI.TO income_statement (annual, 2024-10-31) — Net Income Including Noncontrolling Interests: 2473849.00
CXI.TO cash_flow (annual, 2024-10-31) — Net Intangibles Purchase And Sale: -791209.00
CXI.TO income_statement (annual, 2024-10-31) — Net Interest Income: -1403563.00
CXI.TO income_statement (quarterly, 2024-10-31) — Net Interest Income: -1067331.00
CXI.TO cash_flow (annual, 2024-10-31) — Net Issuance Payments Of Debt: -11723851.00
CXI.TO cash_flow (quarterly, 2024-10-31) — Net Issuance Payments Of Debt: -550686.00
CXI.TO cash_flow (annual, 2024-10-31) — Net Long Term Debt Issuance: -2119343.00
CXI.TO cash_flow (quarterly, 2024-10-31) — Net Long Term Debt Issuance: -549098.00
CXI.TO income_statement (annual, 2024-10-31) — Net Non Operating Interest Income Expense: -1403563.00
CXI.TO cash_flow (annual, 2024-10-31) — Net Other Financing Charges: 232946.00
CXI.TO cash_flow (quarterly, 2024-10-31) — Net Other Financing Charges: 98128.00
CXI.TO balance_sheet (annual, 2024-10-31) — Net PPE: 7789442.00
CXI.TO balance_sheet (quarterly, 2024-10-31) — Net PPE: 7789442.00
CXI.TO cash_flow (annual, 2024-10-31) — Net PPE Purchase And Sale: -2211914.00
CXI.TO cash_flow (quarterly, 2024-10-31) — Net PPE Purchase And Sale: -631708.00
CXI.TO cash_flow (annual, 2024-10-31) — Net Short Term Debt Issuance: -9604508.00
CXI.TO cash_flow (quarterly, 2024-10-31) — Net Short Term Debt Issuance: -1588.00
CXI.TO balance_sheet (annual, 2024-10-31) — Net Tangible Assets: 75960469.00
CXI.TO balance_sheet (quarterly, 2024-10-31) — Net Tangible Assets: 75960469.00
CXI.TO balance_sheet (annual, 2024-10-31) — Non Current Deferred Assets: 1260430.00
CXI.TO balance_sheet (quarterly, 2024-10-31) — Non Current Deferred Assets: 1260430.00
CXI.TO balance_sheet (annual, 2024-10-31) — Non Current Deferred Taxes Assets: 1260430.00
CXI.TO balance_sheet (quarterly, 2024-10-31) — Non Current Deferred Taxes Assets: 1260430.00
CXI.TO income_statement (annual, 2024-10-31) — Normalized EBITDA: 22584190.00
CXI.TO income_statement (quarterly, 2024-10-31) — Normalized EBITDA: 3355176.00
CXI.TO income_statement (annual, 2024-10-31) — Normalized Income: 13475497.87
CXI.TO income_statement (quarterly, 2024-10-31) — Normalized Income: -392869.76
CXI.TO cash_flow (annual, 2024-10-31) — Operating Cash Flow: 26902324.00
CXI.TO cash_flow (quarterly, 2024-10-31) — Operating Cash Flow: -22567179.00
CXI.TO income_statement (annual, 2024-10-31) — Operating Income: 19752066.00
CXI.TO income_statement (quarterly, 2024-10-31) — Operating Income: 3050484.00
CXI.TO income_statement (annual, 2024-10-31) — Operating Revenue: 68921326.00
CXI.TO income_statement (quarterly, 2024-10-31) — Operating Revenue: 23049079.00
CXI.TO balance_sheet (annual, 2024-10-31) — Ordinary Shares Number: 6333931.00
CXI.TO balance_sheet (quarterly, 2024-10-31) — Ordinary Shares Number: 6333931.00
CXI.TO balance_sheet (annual, 2024-10-31) — Other Current Assets: 431680.00
CXI.TO balance_sheet (annual, 2024-10-31) — Other Current Liabilities: 24535981.00
CXI.TO balance_sheet (quarterly, 2024-10-31) — Other Current Liabilities: 24535981.00
CXI.TO balance_sheet (annual, 2024-10-31) — Other Equity Adjustments: -6523785.00
CXI.TO balance_sheet (quarterly, 2024-10-31) — Other Equity Adjustments: -6523785.00
CXI.TO balance_sheet (annual, 2024-10-31) — Other Equity Interest: 3976506.00
CXI.TO income_statement (annual, 2024-10-31) — Other Gand A: 9496290.00
CXI.TO income_statement (quarterly, 2024-10-31) — Other Gand A: 4994219.00
CXI.TO income_statement (annual, 2024-10-31) — Other Income Expense: -390688.00
CXI.TO income_statement (quarterly, 2024-10-31) — Other Income Expense: -3069657.00
CXI.TO balance_sheet (annual, 2024-10-31) — Other Intangible Assets: 2122185.00
CXI.TO cash_flow (annual, 2024-10-31) — Other Non Cash Items: -172870.00
CXI.TO cash_flow (quarterly, 2024-10-31) — Other Non Cash Items: -357269.00
CXI.TO balance_sheet (annual, 2024-10-31) — Other Non Current Assets: 164497.00
CXI.TO balance_sheet (quarterly, 2024-10-31) — Other Non Current Assets: 164497.00
CXI.TO balance_sheet (annual, 2024-10-31) — Other Non Current Liabilities: 2067587.00
CXI.TO income_statement (annual, 2024-10-31) — Other Non Operating Income Expenses: -66.00
CXI.TO income_statement (quarterly, 2024-10-31) — Other Non Operating Income Expenses: -1.00
CXI.TO income_statement (annual, 2024-10-31) — Other Operating Expenses: 3938599.00
CXI.TO income_statement (quarterly, 2024-10-31) — Other Operating Expenses: 2619630.00
CXI.TO balance_sheet (annual, 2024-10-31) — Payables: 15266631.00
CXI.TO balance_sheet (annual, 2024-10-31) — Payables And Accrued Expenses: 18923578.00
CXI.TO balance_sheet (annual, 2024-10-31) — Prepaid Assets: 987206.00
CXI.TO income_statement (annual, 2024-10-31) — Pretax Income: 17957815.00
CXI.TO income_statement (quarterly, 2024-10-31) — Pretax Income: -1086504.00
CXI.TO cash_flow (annual, 2024-10-31) — Proceeds From Stock Option Exercised: -75121.00
CXI.TO balance_sheet (annual, 2024-10-31) — Properties: 0.00
CXI.TO balance_sheet (quarterly, 2024-10-31) — Properties: 0.00
CXI.TO cash_flow (annual, 2024-10-31) — Purchase Of Intangibles: -791209.00
CXI.TO cash_flow (annual, 2024-10-31) — Purchase Of PPE: -2211914.00
CXI.TO balance_sheet (annual, 2024-10-31) — Receivables: 8743640.00
CXI.TO balance_sheet (quarterly, 2024-10-31) — Receivables: 8743640.00
CXI.TO income_statement (annual, 2024-10-31) — Reconciled Cost Of Revenue: 27003320.00
CXI.TO income_statement (quarterly, 2024-10-31) — Reconciled Cost Of Revenue: 9207004.00
CXI.TO income_statement (annual, 2024-10-31) — Reconciled Depreciation: 3770366.00
CXI.TO income_statement (quarterly, 2024-10-31) — Reconciled Depreciation: 1057092.00
CXI.TO income_statement (annual, 2024-10-31) — Rent And Landing Fees: 1712531.00
CXI.TO income_statement (quarterly, 2024-10-31) — Rent And Landing Fees: 535396.00
CXI.TO income_statement (annual, 2024-10-31) — Rent Expense Supplemental: 1712531.00
CXI.TO income_statement (quarterly, 2024-10-31) — Rent Expense Supplemental: 535396.00
CXI.TO cash_flow (annual, 2024-10-31) — Repayment Of Debt: -2119343.00
CXI.TO cash_flow (quarterly, 2024-10-31) — Repayment Of Debt: -549098.00
CXI.TO cash_flow (annual, 2024-10-31) — Repurchase Of Capital Stock: -2749308.00
CXI.TO balance_sheet (annual, 2024-10-31) — Restricted Cash: 3239729.00
CXI.TO balance_sheet (quarterly, 2024-10-31) — Restricted Cash: 3239729.00
CXI.TO income_statement (annual, 2024-10-31) — Restructuring And Mergern Acquisition: 0.00
CXI.TO balance_sheet (annual, 2024-10-31) — Retained Earnings: 45182810.00
CXI.TO balance_sheet (quarterly, 2024-10-31) — Retained Earnings: 45182810.00
CXI.TO income_statement (annual, 2024-10-31) — Salaries And Wages: 1592354.00
CXI.TO income_statement (annual, 2024-10-31) — Selling And Marketing Expense: 855404.00
CXI.TO income_statement (annual, 2024-10-31) — Selling General And Administration: 14456975.00
CXI.TO balance_sheet (annual, 2024-10-31) — Share Issued: 6333931.00
CXI.TO income_statement (annual, 2024-10-31) — Special Income Charges: -63387.00
CXI.TO income_statement (quarterly, 2024-10-31) — Special Income Charges: -2690425.00
CXI.TO cash_flow (annual, 2024-10-31) — Stock Based Compensation: 1592354.00
CXI.TO cash_flow (quarterly, 2024-10-31) — Stock Based Compensation: 206462.00
CXI.TO balance_sheet (annual, 2024-10-31) — Stockholders Equity: 79392355.00
CXI.TO balance_sheet (annual, 2024-10-31) — Tangible Book Value: 75960469.00
CXI.TO balance_sheet (quarterly, 2024-10-31) — Tangible Book Value: 75960469.00
CXI.TO income_statement (annual, 2024-10-31) — Tax Effect Of Unusual Items: -103759.13
CXI.TO income_statement (annual, 2024-10-31) — Tax Provision: 4769246.00
CXI.TO income_statement (quarterly, 2024-10-31) — Tax Provision: 1731394.00
CXI.TO income_statement (annual, 2024-10-31) — Tax Rate For Calcs: 0.27
CXI.TO income_statement (quarterly, 2024-10-31) — Tax Rate For Calcs: 0.21
CXI.TO balance_sheet (annual, 2024-10-31) — Total Assets: 131161584.00
CXI.TO balance_sheet (quarterly, 2024-10-31) — Total Assets: 131161584.00
CXI.TO balance_sheet (annual, 2024-10-31) — Total Capitalization: 79392355.00
CXI.TO balance_sheet (quarterly, 2024-10-31) — Total Capitalization: 79392355.00
CXI.TO balance_sheet (annual, 2024-10-31) — Total Debt: 5753310.00
CXI.TO balance_sheet (annual, 2024-10-31) — Total Equity Gross Minority Interest: 79392355.00
CXI.TO balance_sheet (quarterly, 2024-10-31) — Total Equity Gross Minority Interest: 79392355.00
CXI.TO income_statement (annual, 2024-10-31) — Total Expenses: 49169260.00
CXI.TO income_statement (quarterly, 2024-10-31) — Total Expenses: 19998595.00
CXI.TO balance_sheet (annual, 2024-10-31) — Total Liabilities Net Minority Interest: 51769229.00
CXI.TO balance_sheet (quarterly, 2024-10-31) — Total Liabilities Net Minority Interest: 51769229.00
CXI.TO balance_sheet (annual, 2024-10-31) — Total Non Current Assets: 12646255.00
CXI.TO balance_sheet (quarterly, 2024-10-31) — Total Non Current Assets: 12646255.00
CXI.TO balance_sheet (annual, 2024-10-31) — Total Non Current Liabilities Net Minority Interest: 6673186.00
CXI.TO balance_sheet (quarterly, 2024-10-31) — Total Non Current Liabilities Net Minority Interest: 6673186.00
CXI.TO income_statement (annual, 2024-10-31) — Total Operating Income As Reported: 21633214.00
CXI.TO income_statement (quarterly, 2024-10-31) — Total Operating Income As Reported: 2871127.00
CXI.TO income_statement (annual, 2024-10-31) — Total Other Finance Cost: 1075765.00
CXI.TO income_statement (quarterly, 2024-10-31) — Total Other Finance Cost: 857218.00
CXI.TO balance_sheet (annual, 2024-10-31) — Total Tax Payable: 175557.00
CXI.TO income_statement (annual, 2024-10-31) — Total Unusual Items: -390688.00
CXI.TO income_statement (annual, 2024-10-31) — Total Unusual Items Excluding Goodwill: -390688.00
CXI.TO income_statement (quarterly, 2024-10-31) — Total Unusual Items Excluding Goodwill: -3069656.00
CXI.TO balance_sheet (annual, 2024-10-31) — Working Capital: 73419286.00
CXI.TO income_statement (annual, 2024-10-31) — Write Off: 63387.00
CXI.TO income_statement (quarterly, 2025-01-31) — +Operating Expense: 4965055.00
CXI.TO income_statement (quarterly, 2025-01-31) — +Total Revenue: 15450861.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Accounts Payable: 17878020.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Accounts Receivable: 8381716.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Accumulated Depreciation: -4818399.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Additional Paid In Capital: 29915607.00
CXI.TO income_statement (quarterly, 2025-01-31) — Basic Average Shares: 6299013.00
CXI.TO income_statement (quarterly, 2025-01-31) — Basic EPS: 0.13
CXI.TO cash_flow (quarterly, 2025-01-31) — Beginning Cash Position: 101877263.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Buildings And Improvements: 6631585.00
CXI.TO cash_flow (quarterly, 2025-01-31) — Capital Expenditure: -415628.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Capital Lease Obligations: 7497066.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Capital Stock: 6301204.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Cash And Cash Equivalents: 92889765.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Cash Cash Equivalents And Short Term Investments: 92889765.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Cash Financial: 92889765.00
CXI.TO cash_flow (quarterly, 2025-01-31) — Cash Flow From Continuing Financing Activities: -731979.00
CXI.TO cash_flow (quarterly, 2025-01-31) — Cash Flow From Continuing Investing Activities: -415628.00
CXI.TO cash_flow (quarterly, 2025-01-31) — Cash Flow From Continuing Operating Activities: -6988099.00
CXI.TO cash_flow (quarterly, 2025-01-31) — Change In Account Payable: -8112807.00
CXI.TO cash_flow (quarterly, 2025-01-31) — Change In Other Current Assets: -635581.00
CXI.TO cash_flow (quarterly, 2025-01-31) — Change In Other Working Capital: -2120288.00
CXI.TO cash_flow (quarterly, 2025-01-31) — Change In Payable: -8112807.00
CXI.TO cash_flow (quarterly, 2025-01-31) — Change In Payables And Accrued Expense: -8112807.00
CXI.TO cash_flow (quarterly, 2025-01-31) — Change In Receivables: 2534648.00
CXI.TO cash_flow (quarterly, 2025-01-31) — Change In Working Capital: -8334028.00
CXI.TO cash_flow (quarterly, 2025-01-31) — Changes In Account Receivables: 2534648.00
CXI.TO cash_flow (quarterly, 2025-01-31) — Changes In Cash: -8135706.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Common Stock: 6301204.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Common Stock Equity: 79446877.00
CXI.TO cash_flow (quarterly, 2025-01-31) — Common Stock Payments: -562434.00
CXI.TO income_statement (quarterly, 2025-01-31) — Cost Of Revenue: 7071453.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Current Accrued Expenses: 7369843.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Current Assets: 109933013.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Current Capital Lease Obligation: 1654932.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Current Debt: 5224614.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Current Debt And Capital Lease Obligation: 6879546.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Current Deferred Liabilities: 397593.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Current Deferred Revenue: 397593.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Current Liabilities: 36298066.00
CXI.TO cash_flow (quarterly, 2025-01-31) — Depreciation: 871663.00
CXI.TO cash_flow (quarterly, 2025-01-31) — Depreciation Amortization Depletion: 871663.00
CXI.TO income_statement (quarterly, 2025-01-31) — Depreciation Amortization Depletion Income Statement: 871663.00
CXI.TO cash_flow (quarterly, 2025-01-31) — Depreciation And Amortization: 871663.00
CXI.TO income_statement (quarterly, 2025-01-31) — Depreciation And Amortization In Income Statement: 871663.00
CXI.TO income_statement (quarterly, 2025-01-31) — Depreciation Income Statement: 871663.00
CXI.TO income_statement (quarterly, 2025-01-31) — Diluted Average Shares: 6539817.00
CXI.TO income_statement (quarterly, 2025-01-31) — Diluted EPS: 0.12
CXI.TO income_statement (quarterly, 2025-01-31) — Diluted NI Availto Com Stockholders: 812530.00
CXI.TO income_statement (quarterly, 2025-01-31) — EBIT: 2982086.00
CXI.TO income_statement (quarterly, 2025-01-31) — EBITDA: 3853749.00
CXI.TO cash_flow (quarterly, 2025-01-31) — Effect Of Exchange Rate Changes: -851792.00
CXI.TO cash_flow (quarterly, 2025-01-31) — End Cash Position: 92889765.00
CXI.TO cash_flow (quarterly, 2025-01-31) — Financing Cash Flow: -731979.00
CXI.TO cash_flow (quarterly, 2025-01-31) — Free Cash Flow: -7403727.00
CXI.TO income_statement (quarterly, 2025-01-31) — Gain On Sale Of Security: -278863.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Gains Losses Not Affecting Retained Earnings: -6813376.00
CXI.TO income_statement (quarterly, 2025-01-31) — General And Administrative Expense: 2811377.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Goodwill: 1309701.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Goodwill And Other Intangible Assets: 3466603.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Gross PPE: 13808624.00
CXI.TO income_statement (quarterly, 2025-01-31) — Gross Profit: 8379408.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Hedging Assets Current: 521347.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Income Tax Payable: 597114.00
CXI.TO income_statement (quarterly, 2025-01-31) — Insurance And Claims: 257131.00
CXI.TO income_statement (quarterly, 2025-01-31) — Interest Expense: 143823.00
CXI.TO income_statement (quarterly, 2025-01-31) — Interest Expense Non Operating: 143823.00
CXI.TO income_statement (quarterly, 2025-01-31) — Interest Income: 30743.00
CXI.TO income_statement (quarterly, 2025-01-31) — Interest Income Non Operating: 30743.00
CXI.TO cash_flow (quarterly, 2025-01-31) — Interest Paid Supplemental Data: 56361.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Invested Capital: 84671491.00
CXI.TO cash_flow (quarterly, 2025-01-31) — Investing Cash Flow: -415628.00
CXI.TO cash_flow (quarterly, 2025-01-31) — Issuance Of Debt: 401518.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Leases: 3976825.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Line Of Credit: 5224614.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Long Term Capital Lease Obligation: 5842134.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Long Term Debt And Capital Lease Obligation: 5842134.00
CXI.TO cash_flow (quarterly, 2025-01-31) — Long Term Debt Issuance: 401518.00
CXI.TO cash_flow (quarterly, 2025-01-31) — Long Term Debt Payments: -564080.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Machinery Furniture Equipment: 3200214.00
CXI.TO cash_flow (quarterly, 2025-01-31) — Net Common Stock Issuance: -562434.00
CXI.TO income_statement (quarterly, 2025-01-31) — Net Income: 812530.00
CXI.TO income_statement (quarterly, 2025-01-31) — Net Income Common Stockholders: 812530.00
CXI.TO income_statement (quarterly, 2025-01-31) — Net Income Continuous Operations: 1694672.00
CXI.TO income_statement (quarterly, 2025-01-31) — Net Income Discontinuous Operations: -882142.00
CXI.TO income_statement (quarterly, 2025-01-31) — Net Income From Continuing And Discontinued Operation: 812530.00
CXI.TO income_statement (quarterly, 2025-01-31) — Net Income From Continuing Operation Net Minority Interest: 1694672.00
CXI.TO cash_flow (quarterly, 2025-01-31) — Net Income From Continuing Operations: 812530.00
CXI.TO income_statement (quarterly, 2025-01-31) — Net Income Including Noncontrolling Interests: 812530.00
CXI.TO cash_flow (quarterly, 2025-01-31) — Net Intangibles Purchase And Sale: -183498.00
CXI.TO income_statement (quarterly, 2025-01-31) — Net Interest Income: -297227.00
CXI.TO cash_flow (quarterly, 2025-01-31) — Net Issuance Payments Of Debt: -162562.00
CXI.TO cash_flow (quarterly, 2025-01-31) — Net Long Term Debt Issuance: -162562.00
CXI.TO income_statement (quarterly, 2025-01-31) — Net Non Operating Interest Income Expense: -297227.00
CXI.TO cash_flow (quarterly, 2025-01-31) — Net Other Financing Charges: 100207.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Net PPE: 8990225.00
CXI.TO cash_flow (quarterly, 2025-01-31) — Net PPE Purchase And Sale: -232130.00
CXI.TO cash_flow (quarterly, 2025-01-31) — Net Short Term Debt Issuance: 401518.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Net Tangible Assets: 75980274.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Non Current Deferred Assets: 543003.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Non Current Deferred Taxes Assets: 543003.00
CXI.TO income_statement (quarterly, 2025-01-31) — Normalized EBITDA: 4132612.00
CXI.TO income_statement (quarterly, 2025-01-31) — Normalized Income: 1861989.80
CXI.TO cash_flow (quarterly, 2025-01-31) — Operating Cash Flow: -6988099.00
CXI.TO income_statement (quarterly, 2025-01-31) — Operating Income: 3414353.00
CXI.TO income_statement (quarterly, 2025-01-31) — Operating Revenue: 15450861.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Ordinary Shares Number: 6301204.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Other Current Assets: 972385.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Other Current Liabilities: 3175950.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Other Equity Adjustments: -6813376.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Other Equity Interest: 4048102.00
CXI.TO income_statement (quarterly, 2025-01-31) — Other Gand A: 2173428.00
CXI.TO income_statement (quarterly, 2025-01-31) — Other Income Expense: -278863.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Other Intangible Assets: 2156902.00
CXI.TO cash_flow (quarterly, 2025-01-31) — Other Non Cash Items: -264062.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Other Non Current Assets: 182349.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Other Non Current Liabilities: 1528116.00
CXI.TO income_statement (quarterly, 2025-01-31) — Other Operating Expenses: 966835.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Payables: 18475134.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Payables And Accrued Expenses: 25844977.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Prepaid Assets: 1483449.00
CXI.TO income_statement (quarterly, 2025-01-31) — Pretax Income: 2838263.00
CXI.TO cash_flow (quarterly, 2025-01-31) — Proceeds From Stock Option Exercised: -6983.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Properties: 0.00
CXI.TO cash_flow (quarterly, 2025-01-31) — Purchase Of Intangibles: -183498.00
CXI.TO cash_flow (quarterly, 2025-01-31) — Purchase Of PPE: -232130.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Receivables: 8381716.00
CXI.TO income_statement (quarterly, 2025-01-31) — Reconciled Cost Of Revenue: 7071453.00
CXI.TO income_statement (quarterly, 2025-01-31) — Reconciled Depreciation: 871663.00
CXI.TO income_statement (quarterly, 2025-01-31) — Rent And Landing Fees: 455020.00
CXI.TO income_statement (quarterly, 2025-01-31) — Rent Expense Supplemental: 455020.00
CXI.TO cash_flow (quarterly, 2025-01-31) — Repayment Of Debt: -564080.00
CXI.TO cash_flow (quarterly, 2025-01-31) — Repurchase Of Capital Stock: -562434.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Restricted Cash: 5684351.00
CXI.TO income_statement (quarterly, 2025-01-31) — Restructuring And Mergern Acquisition: 0.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Retained Earnings: 45995340.00
CXI.TO income_statement (quarterly, 2025-01-31) — Salaries And Wages: -74202.00
CXI.TO income_statement (quarterly, 2025-01-31) — Selling And Marketing Expense: 315180.00
CXI.TO income_statement (quarterly, 2025-01-31) — Selling General And Administration: 3126557.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Share Issued: 6301204.00
CXI.TO income_statement (quarterly, 2025-01-31) — Special Income Charges: 0.00
CXI.TO cash_flow (quarterly, 2025-01-31) — Stock Based Compensation: -74202.00